US: 1.917.963.8646 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
The global biopharmaceutical industry is the most rapidly growing industry in the science and technology sector owing to increasing R&D investments in biopharmaceutical drug development facilities. The global automation market in biopharmaceutical industry includes deployment of automation in biopharmaceutical academic research centers, manufacturing and research companies, clinical labs, and government approved labs. One trend in the market is continuous manufacturing. Advantages of continuous operations are well-recognized in various industries. It completes the process in a shorter time as it omits the hold steps, reduces shut down time, and reduces the labor requirement. Over the decades, upstream processing utilized this technology.” According to the report, one driver in the market is use of automation in data acquisition. Traditionally, research labs collect data manually and store it in spreadsheets. This method is not only time-consuming but also affects operational efficiency and is prone to errors. It also restricts monitoring of data in real time. The biopharmaceutical industry is working on data collection and adding the information from spreadsheets to a database. Database collection of upstream and downstream processes is being utilized to create a library that increases operational efficiency and process optimization. Further, the report states that one challenge in the market is high R&D cost. The biopharmaceutical industry is a rapidly growing industry in pharmaceuticals. Complex drugs are manufactured with the help of 3-D modeling and are produced with high efficacy and precision. These drugs can provide medication to medical issues that were once incurable. Currently, the biopharmaceutical industry is looking to yield new products to address diseases such as cancer, Alzheimer's disease, and hepatitis C. Innovations in the biopharmaceutical industry are highly expensive. The average cost associated with a new drug is around $2 billion, including the cost of unsuccessful drug approvals, out of which almost $400 million is the cost included in pre-clinical and clinical testing. The global Automation in Biopharmaceutical market is valued at 1040 million US$ in 2018 is expected to reach 1590 million US$ by the end of 2025, growing at a CAGR of 6.2% during 2019-2025. This report focuses on Automation in Biopharmaceutical volume and value at global level, regional level and company level. From a global perspective, this report represents overall Automation in Biopharmaceutical market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report. The following manufacturers are covered: Danaher GE PerkinElmer Tecan Trading Thermo Fisher Scientific Bruker Peak Analysis & Automation Waters Capsugel RheoSense Eirechrom BioProcess International Novasep Segment by Regions North America Europe China Japan Segment by Type Clinical stage automation Drug discovery stage automation Segment by Application Research and Development Clinical
Table of Contents Executive Summary 1 Automation in Biopharmaceutical Market Overview 1.1 Product Overview and Scope of Automation in Biopharmaceutical 1.2 Automation in Biopharmaceutical Segment by Type 1.2.1 Global Automation in Biopharmaceutical Production Growth Rate Comparison by Type (2014-2025) 1.2.2 Clinical stage automation 1.2.3 Drug discovery stage automation 1.3 Automation in Biopharmaceutical Segment by Application 1.3.1 Automation in Biopharmaceutical Consumption Comparison by Application (2014-2025) 1.3.2 Research and Development 1.3.3 Clinical 1.4 Global Automation in Biopharmaceutical Market by Region 1.4.1 Global Automation in Biopharmaceutical Market Size Region 1.4.2 North America Status and Prospect (2014-2025) 1.4.3 Europe Status and Prospect (2014-2025) 1.4.4 China Status and Prospect (2014-2025) 1.4.5 Japan Status and Prospect (2014-2025) 1.5 Global Automation in Biopharmaceutical Market Size 1.5.1 Global Automation in Biopharmaceutical Revenue (2014-2025) 1.5.2 Global Automation in Biopharmaceutical Production (2014-2025) 2 Global Automation in Biopharmaceutical Market Competition by Manufacturers 2.1 Global Automation in Biopharmaceutical Production Market Share by Manufacturers (2014-2019) 2.2 Global Automation in Biopharmaceutical Revenue Share by Manufacturers (2014-2019) 2.3 Global Automation in Biopharmaceutical Average Price by Manufacturers (2014-2019) 2.4 Manufacturers Automation in Biopharmaceutical Production Sites, Area Served, Product Types 2.5 Automation in Biopharmaceutical Market Competitive Situation and Trends 2.5.1 Automation in Biopharmaceutical Market Concentration Rate 2.5.2 Automation in Biopharmaceutical Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Automation in Biopharmaceutical Production Market Share by Regions 3.1 Global Automation in Biopharmaceutical Production Market Share by Regions 3.2 Global Automation in Biopharmaceutical Revenue Market Share by Regions (2014-2019) 3.3 Global Automation in Biopharmaceutical Production, Revenue, Price and Gross Margin (2014-2019) 3.4 North America Automation in Biopharmaceutical Production 3.4.1 North America Automation in Biopharmaceutical Production Growth Rate (2014-2019) 3.4.2 North America Automation in Biopharmaceutical Production, Revenue, Price ... | read more...